Encompass Health (EHC) Q4 2025: Premium Labor Spend Drops $21M, Fueling Margin Expansion and Growth Capacity

2026-02-06 | By EarningsIQ Research

Encompass Health’s disciplined cost control and strong capacity expansion defined Q4, with premium labor spend falling to a four-year low and new hospital ramp-ups outpacing expectations. Regulatory headwinds, payer friction, and evolving site-of-care models remain front-of-mind, but management’s playbook emphasizes operational leverage, strategic market density, and a robust pipeline of capacity additions for 2026 and beyond. Guidance signals confidence in demand durability and margin resilience, even as the regulatory and payer environment grows more complex.

Summary

• Labor Efficiency Inflection: Premium labor costs hit post-pandemic lows, unlocking margin headroom.
• Capacity Expansion Momentum: New hospital ramp-ups and small-format strategy accelerate geographic reach.
• Payer and Regulatory Navigation: Assertive admit-and-appeal tactics and regulatory preparedness underpin 2026 outlook.

Business Overview

Encompass Health (EHC) is the largest owner and operator of inpatient rehabilitation facilities (IRFs) in the United States. The company generates revenue primarily from patient discharges, with reimbursement from Medicare, Medicare Advantage (MA), managed care, and other payers. Its business model hinges on high-quality clinical outcomes and operational scale, with growth driven by new hospital openings, bed additions, and joint venture partnerships. Major segments include core IRF operations, de novo (new build) hospitals, and managed care contract management.

Performance Analysis

Q4 capped a year of robust volume and disciplined cost management for Encompass Health. Discharge growth and favorable pricing drove double-digit revenue and EBITDA gains, with operating leverage amplified by a sharp reduction in premium labor spend—down $5.8 million YoY in Q4 and over $21 million for the year. Notably, premium labor (contract labor and bonuses) as a share of total labor cost hit its lowest level since early 2021, aided by improved hiring, retention, and a softening labor market.

Free cash flow surged 23.6% in Q4, supporting $736 million in capital expenditures, $158 million in share repurchases, and $71 million in dividends, all while maintaining net leverage at 1.9x. Operationally, new hospitals ramped faster than forecast, with four of eight 2025 openings delivering positive EBITDA in Q4, benefiting from quicker-than-expected Medicare certifications. Patient mix continued to favor high-acuity, IRF-appropriate cases, and the company’s discharge-to-community and quality metrics outperformed industry averages.

• Labor Cost Reset: Contract labor FTEs fell to 1.1% of total FTEs, driving margin expansion.
• Volume and Mix: Broad-based growth across brain injury, cardiac, neuro, trauma, and stroke, with brain injury discharges up 8.7% YoY.
• Cash Flow Strength: Elevated free cash flow funded both growth investments and shareholder returns without increasing leverage.

Managed care volume rose, especially through the Veterans Community Care Network (now 19% of managed care volume), while challenges with a national MA plan’s conversion rates prompted new admit-and-appeal strategies for 2026. The company’s market capture in high-acuity categories and ability to backfill volume across payer classes remain key levers.

Executive Commentary

Strategic Positioning

1. Labor Model Transformation

Encompass Health’s operational discipline in labor management is a material earnings driver. The company leveraged a centralized talent acquisition team and clinical ladder programs, reducing turnover and premium labor reliance. With 300 net RNs added same-store in 2025 and turnover at pre-pandemic levels, EHC is positioned to further narrow labor cost variation across markets.

2. Capacity Expansion and Small-Format Hospitals

Capacity investments are core to EHC’s growth algorithm. In 2025, 517 beds were added (eight new hospitals and bed additions), and a new small-format hospital model will launch in 2027. These 24-bed, single-story facilities enable market densification via a hub-and-spoke approach, expanding reach in both large metros and underserved fringe markets. The model leverages existing management resources, avoids new Medicare certifications, and supports rapid scaling.

3. Payer and Regulatory Adaptation

Management is proactively addressing regulatory and payer headwinds. The company’s high affirmation rates under Review Choice Demonstration (RCD) and assertive admit-and-appeal strategies for MA denials reflect a playbook honed over years of episodic payment pilots. RCD and TEAM (Transitional Care Episode Model) are framed as business-as-usual, with minimal expected volume or margin impact in 2026. Backfilling with fee-for-service, other MA plans, and VA network patients remains a focus.

4. Technology and Data-Driven Operations

The expanded Palantir partnership is driving administrative efficiency and market analytics. Initiatives include streamlined admission documentation, denial management, and deployment of AI tools in revenue cycle and clinical staffing optimization. These investments are expected to reduce manual workload, improve claim affirmation, and inform market development strategy.

5. Balance Sheet and Capital Allocation

Strong free cash flow and low leverage provide flexibility for continued growth and shareholder returns. Management signaled potential for increased buybacks and dividends in 2026, with no significant change in provider tax exposure or malpractice trends anticipated.

Key Considerations

This quarter’s results underscore Encompass Health’s focus on operational excellence, capacity-led growth, and regulatory resilience, with several strategic dynamics shaping the 2026 investment case.

Key Considerations:

• Labor Market Tailwinds: Softening labor conditions and internal retention efforts support further margin gains.
• Market Density Strategy: Small-format hospitals unlock new geographies and deepen competitive moats in core markets.
• Payer Mix Volatility: Medicare Advantage conversion remains a friction point, but the company’s admit-and-appeal approach and fee-for-service backfill mitigate risk.
• Regulatory Preparedness: High affirmation rates and experience with episodic payment models position EHC to absorb RCD and TEAM transitions with minimal disruption.
• Capital Deployment Discipline: Robust cash flow funds both organic growth and shareholder returns, with leverage well within target range.

Risks

Key risks include regulatory unpredictability, payer pushback—especially from Medicare Advantage plans— and potential for site-of-care shifts under new episodic payment models. While management frames RCD and TEAM as manageable, persistent payer denials or more aggressive regulatory changes could pressure volume or reimbursement. Market closures and unit consolidations, while mitigated, present near-term headwinds to discharge growth. Macroeconomic shocks or labor market tightening could also challenge margin stability.

Forward Outlook

For Q1 2026, Encompass Health guided to:

• Net operating revenue of $6.365 billion to $6.465 billion
• Adjusted EBITDA of $1.34 to $1.38 billion
• Adjusted EPS of $5.81 to $6.10

For full-year 2026, management maintained guidance and highlighted:

• Continued investment in capacity additions and small-format hospital rollout
• Ongoing focus on labor efficiency and clinical quality

Leadership emphasized confidence in demand durability, margin preservation, and the ability to offset regulatory and payer headwinds through operational agility and market development.

Takeaways

Encompass Health’s Q4 and full-year 2025 results signal a business executing on multiple fronts, with margin expansion, capacity growth, and regulatory navigation at the forefront.

• Labor and Operating Leverage: Sustained premium labor cost reduction and improved retention are expanding margins and enabling growth without sacrificing care quality.
• Capacity-Led Growth: The introduction of small-format hospitals and rapid ramp-up of new facilities position EHC for continued market share gains.
• Regulatory and Payer Resilience: Assertive strategies and historical experience underpin confidence in guidance despite a dynamic regulatory and payer environment.

Conclusion

Encompass Health enters 2026 with strong momentum, underpinned by disciplined execution, a robust capital position, and a clear strategy for growth and risk management. Investors should watch for further labor cost normalization, payer mix evolution, and the scaling of small-format hospitals as key drivers of the company’s trajectory.

Industry Read-Through

Encompass Health’s quarter provides a clear read-through for the post-acute and broader healthcare services sector. Labor cost normalization and operational discipline are achievable levers for margin expansion industry-wide, especially as labor market pressures ease. The shift toward market density and small-format expansion could influence competitive dynamics in both rehabilitation and acute care, offering a template for scaling in fragmented or capacity-constrained markets. Payer mix volatility and regulatory pilots like TEAM and RCD are likely to remain sector-wide headwinds, with success hinging on proactive appeal strategies and data-driven value demonstration. Expect continued focus on technology partnerships and administrative automation as providers seek to offset reimbursement and volume pressures.

EHC Healthcare Post-Acute Regulatory Labor Capacity Medicare Growth